Stéphane Demotz

2.0k total citations
43 papers, 1.7k citations indexed

About

Stéphane Demotz is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Stéphane Demotz has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 19 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Stéphane Demotz's work include Immunotherapy and Immune Responses (16 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (10 papers). Stéphane Demotz is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (10 papers). Stéphane Demotz collaborates with scholars based in Switzerland, United States and France. Stéphane Demotz's co-authors include Alessandro Sette, Howard M. Grey, Antonio Lanzavecchia, Giampietro Corradin, G Corradin, H M Grey, Ettore Appella, Catherine Barbey, Christian Widmann and Ulrich Eisel and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Stéphane Demotz

43 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Demotz Switzerland 21 970 725 319 218 114 43 1.7k
Horacio M. Serra Argentina 19 1.2k 1.2× 612 0.8× 374 1.2× 228 1.0× 55 0.5× 72 1.9k
E J Brown United States 24 974 1.0× 424 0.6× 254 0.8× 238 1.1× 165 1.4× 37 1.9k
Scheherazade Sadegh‐Nasseri United States 27 1.8k 1.9× 742 1.0× 476 1.5× 150 0.7× 53 0.5× 67 2.3k
Rita De Santis Italy 23 1.2k 1.3× 642 0.9× 398 1.2× 259 1.2× 63 0.6× 82 2.3k
Ole Werdelin Denmark 22 967 1.0× 652 0.9× 345 1.1× 112 0.5× 79 0.7× 76 1.6k
Hua-Poo Su United States 20 676 0.7× 583 0.8× 120 0.4× 380 1.7× 91 0.8× 33 1.7k
Morris O. Dailey United States 25 1.2k 1.2× 431 0.6× 247 0.8× 180 0.8× 58 0.5× 43 1.9k
Bärbel S. Blaum Germany 22 927 1.0× 563 0.8× 132 0.4× 166 0.8× 170 1.5× 36 1.9k
Ragnar Lindstedt Italy 21 567 0.6× 399 0.6× 175 0.5× 167 0.8× 45 0.4× 28 1.3k
James M. Sodetz United States 26 1.1k 1.1× 702 1.0× 131 0.4× 89 0.4× 286 2.5× 65 2.0k

Countries citing papers authored by Stéphane Demotz

Since Specialization
Citations

This map shows the geographic impact of Stéphane Demotz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Demotz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Demotz more than expected).

Fields of papers citing papers by Stéphane Demotz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Demotz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Demotz. The network helps show where Stéphane Demotz may publish in the future.

Co-authorship network of co-authors of Stéphane Demotz

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Demotz. A scholar is included among the top collaborators of Stéphane Demotz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Demotz. Stéphane Demotz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Sha, Anh Tuấn Trần, A.B. Boraston, et al.. (2021). Iminosugar C‐Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare Disease**. Chemistry - A European Journal. 27(44). 11291–11297. 5 indexed citations
2.
Zoete, Vincent, Estelle Gallienne, Roger Martí, et al.. (2018). 4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations. Bioorganic & Medicinal Chemistry. 26(20). 5462–5469. 12 indexed citations
3.
Burda, Patricie, Diana Ballhausen, Katsumi Higaki, et al.. (2016). (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B. European Journal of Medicinal Chemistry. 126. 160–170. 28 indexed citations
4.
Dunkel, N., Laure Willen, Margret L. Casal, et al.. (2011). Molecular and Therapeutic Characterization of Anti-ectodysplasin A Receptor (EDAR) Agonist Monoclonal Antibodies. Journal of Biological Chemistry. 286(35). 30769–30779. 32 indexed citations
5.
Casal, Margret L., John R. Lewis, Elizabeth A. Mauldin, et al.. (2007). Significant Correction of Disease after Postnatal Administration of Recombinant Ectodysplasin A in Canine X-Linked Ectodermal Dysplasia. The American Journal of Human Genetics. 81(5). 1050–1056. 87 indexed citations
6.
Nahimana, Aimable, Lucienne Lagopoulos, Antoine Attinger, et al.. (2005). A Fas agonist induces high levels of apoptosis in haematological malignancies. Leukemia Research. 30(4). 415–426. 36 indexed citations
7.
Thierry, Alain R., Nicola Beltraminelli, Pascal Cousin, et al.. (2004). A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate. Vaccine. 23(4). 480–488. 5 indexed citations
8.
Masina, Slavica, Michael M. Gicheru, Stéphane Demotz, & Nicolás Fasel. (2003). Protection against Cutaneous Leishmaniasis in Outbred Vervet Monkeys, Using a Recombinant Histone H1 Antigen. The Journal of Infectious Diseases. 188(8). 1250–1257. 48 indexed citations
9.
Hannier, Sigrid, et al.. (2002). Tuning of T Cell Clone Size and Activation Threshold by Control of CD25 Expression through Mitogen-Activated Protein Kinase Pathways. International Archives of Allergy and Immunology. 127(4). 322–332. 7 indexed citations
10.
Demotz, Stéphane, Corinne Moulon, Mario A. Roggero, Nicolás Fasel, & Slavica Masina. (2001). Native-like, long synthetic peptides as components of sub-unit vaccines: practical and theoretical considerations for their use in humans. Molecular Immunology. 38(6). 415–422. 13 indexed citations
11.
Bouche, Fabienne B., et al.. (2000). Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes. Journal of Immunological Methods. 242(1-2). 145–157. 13 indexed citations
12.
Ammerlaan, Wim, Claude P. Muller, Isabelle Cloutier, et al.. (1997). The processing routes determined by negatively charged residues in DR1-restricted T cell determinants. The Journal of Immunology. 159(7). 3238–3246. 20 indexed citations
13.
Wallny, Hans‐Joachim, et al.. (1996). Cell type‐specific processing of the I‐Ed‐restricted hen egg lysozyme determinant 107–116. European Journal of Immunology. 26(7). 1656–1659. 13 indexed citations
14.
Demotz, Stéphane & Annick Péleraux. (1996). Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways. Molecular Immunology. 33(4-5). 387–397. 15 indexed citations
15.
Demotz, Stéphane, Carlo Danieli, Hans‐Joachim Wallny, & Otto Majdic. (1994). Inhibition of peptide binding to DR molecules by a leupeptin-induced invariant chain fragment. Molecular Immunology. 31(12). 885–893. 5 indexed citations
16.
Demotz, Stéphane, Catherine Barbey, Giampietro Corradin, Antonio Amoroso, & Antonio Lanzavecchia. (1993). The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. European Journal of Immunology. 23(2). 425–432. 100 indexed citations
17.
Grey, H M, Stéphane Demotz, Søren Buus, & A Sette. (1989). Studies on the Nature of Physiologically Processed Antigen and on the Conformation of Peptides Required for Interaction with MHC. Cold Spring Harbor Symposia on Quantitative Biology. 54(0). 393–399. 2 indexed citations
18.
Demotz, Stéphane, Paolo Maria Matricardi, Antonio Lanzavecchia, & Giampietro Corradin. (1989). A novel and simple procedure for determining T cell epitopes in protein antigens. Journal of Immunological Methods. 122(1). 67–72. 22 indexed citations
19.
Panina‐Bordignon, Paola, Stéphane Demotz, G Corradin, & Antonio Lanzavecchia. (1989). Study on the Immunogenicity of Human Class-II-restricted T-cell Epitopes: Processing Constraints, Degenerate Binding, and Promiscuous Recognition. Cold Spring Harbor Symposia on Quantitative Biology. 54(0). 445–451. 16 indexed citations
20.
Roosnek, Eddy, Stéphane Demotz, G Corradin, & Antonio Lanzavecchia. (1988). Kinetics of MHC-antigen complex formation on antigen-presenting cells.. The Journal of Immunology. 140(12). 4079–4082. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026